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and apical-basal cell polarity pathways. The apical-basal
polarity protein Scribble plays a critical role in CE and
other PCP-dependent events during mammalian em-
bryogenesis (Montcouquiol et al., 2003; Murdoch et al.,
2003). The apical-basal polarity pathway regulates PCP
signaling in the Drosophila eye, where dPatj binds and
regulates the activity of Frizzled (Djiane et al., 2005). In
addition, the PCP signaling protein Dishevelled binds
and regulates the activity of the apical-basal polarity pro-
tein Lethal giant larvae (Dollar et al., 2005). Maybe the
apical-basal polarity landmarks in dividing neural pro-
genitors help to reestablish PCP after completion of mi-
tosis, and this newly found PCP helps to reintegrate
daughters into the neuroepithelium?
Ciruna and colleagues demonstrated that the wild-
type but not the tri mutant neural progenitors can rees-
tablish PCP and reintegrate into neuroepithelium (Ciruna
et al., 2006). How is the reestablishment of PCP upon
completion of mitosis connected with the ability of
daughter cells to reintegrate? Carefully orchestrated
changes in intercellular adhesion may be involved in
this process. It is tantalizing that the important PCP pro-
teins Flamingo, Dachsous, and Fat belong to the cad-
herin superfamily of cell-cell adhesion molecules. Maybe
some of these giant cadherins connect mitotic cells with
their neighbors and help to guide reestablishment of
strong intercellular adhesion upon reintegration into
neuroepithelium. Future research will help unravel the
infinitely complex mechanisms governing cell interac-
tions responsible for the proper execution of embryonic
development.
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Competing with Chordin
The enigma of Sizzled, a secreted Frizzled-related pro-
tein, has been resolved in a recent study from the De
Robertis lab (Lee et al., 2006 [in the January 13 issue
of Cell ]). Sizzled, although homologous to other Wnt
antagonists, does not function as such, nor does it
function within a Wnt signaling pathway. Remarkably
it functions as an antagonist of BMP signaling, com-
peting with Chordin for binding to its inhibitor a
Tolloid-related metalloprotease. This competition pro-
tects Chordin from cleavage, thus allowing it to bind
and limit BMP signaling.
Sizzled is related to the Wnt receptor Frizzled, but lacks
a transmembrane domain, causing it to be secreted,
rather than localized to the plasma membrane. A family
of such secreted Frizzled-related proteins includes
sFRP and Crescent proteins, which can bind Wnt li-
gands, sequestering them from their receptors and
thus antagonizing Wnt signaling. Surprisingly, Sizzled
can bind Wnt proteins in vitro, but cannot block Wnt sig-naling in vivo (Bradley et al., 2000). It was thought that
Sizzled may act on an as yet untested or unidentified
Wnt.
In parallel, genetic screens in zebrafish identified sev-
eral mutants with defects in dorsoventral patterning of
the embryonic axis, all shown to be components of
a BMP signaling pathway (Hammerschmidt and Mullins,
2002). Among them a ventralized mutant Ogon exhibits
a similar strength phenotype to the chordin mutant,
chordino. Cloning of the ogon gene unexpectedly re-
vealed that it encodes Sizzled (Yabe et al., 2003). The
dorsalizing activity of Sizzled, also found in Xenopus
(Bradley et al., 2000; Collavin and Kirschner, 2003), was
further shown in zebrafish to depend entirely on the func-
tion of the BMP antagonist Chordin; Szl overexpression
failed to dorsalize chordino mutant embryos. Equally
perplexing is that while Szl dorsalizing activity depends
on Chordin, Szl is expressed ventrally and Chordin dor-
sally. Thus, the presumptive Wnt antagonist Szl was
thrust into a new pathway, regulating BMP signaling.
But how could a secreted Frizzled be regulating BMP
signaling? Szl depended on Chordin, but how? A first
clue from the current study (Lee et al., 2006) was that
Chordin protein levels were reduced in Szl knockdown
Xenopus embryos, despite normal levels of chordin
Previews
155mRNA. Chordin is regulated by metalloproteases of the
Tolloid family, so the activity of Szl was examined rela-
tive to a member of this family highly expressed during
gastrulation called Xolloid-related (Xlr) (Dale et al.,
2002). Xlr overexpression ventralizes the embryo by
cleaving and inactivating Chordin, eliciting a similar phe-
notype to loss of Chordin itself, as expected. Expres-
sion of Szl in chordin knockdown or Xlr overexpressing
embryos, which otherwise exhibit similar ventralized
phenotypes, had profoundly different effects: Szl had
no effect in chordin knockdown embryos, but it com-
pletely suppressed the ventralizing ability of Xlr overex-
pression. Biochemically Xlr overexpression causes
a loss of Chordin, similar to morpholino knockdown of
chordin itself, yet when Szl is overexpressed in these
two conditions, the consequences are strikingly differ-
ent. Together these results lead to the important conclu-
sion that Szl acts upstream of Xlr to negatively regulate
its activity (Figure 1).
Biochemistry combined with molecular embryology
was then used to nail down the relationship between
Xlr and Szl. The authors demonstrated in vitro that Szl
binds Xlr and does so directly, with similar affinity to
that of Chordin. Not only could it bind, but it blocked
proteolysis of Chordin by Xlr in vitro. A mutant form of
Szl lacking activity in zebrafish bound Xlr with a 10-
fold lower affinity, lacked dorsalizing activity in Xeno-
pus, and failed to block Xlr proteolysis of Chordin.
Thus the ability to bind Xlr correlated with Szl dorsaliz-
ing function and its ability to protect Chordin from Xlr
proteolytic activity.
The authors show that Szl is not cleaved by Xlr itself
and instead acts as a competitive inhibitor. Szl could
compete with a heptapeptide substrate that binds to
the active site of the related BMP1 metalloprotease
and inhibit its cleavage. Thus, Szl appears to act by
competing for binding to the active site of Tolloid and
BMP1 metalloproteases, yet is not a substrate itself,
but a competitor of substrates. Importantly, the authors
show that the parameters they identify in their biochem-
Figure 1. Regulatory Interactions between Sizzled, Tolloid, Chordin,
and BMP
Protein interactions are shown in black and transcriptional regula-
tion in pink. Each protein is shown in the dorsal (D) or ventral (V) re-
gion where it is transcribed. BMP signaling is regulated through a se-
ries of negative interactions between these proteins. In ventral
regions BMP signaling positively regulates sizzled and tolloid (tld)
expression and negatively regulates chordin (chd) expression.ical studies are consistent with the physiological levels
of Szl and Chordin found in gastrula-stage embryos,
providing crucial support for the in vivo relevance of
their biochemical studies.
What are the implications of this study on the regula-
tion of BMP signaling and the presumptive BMP gradi-
ent that patterns cells along the dorsoventral axis?
Loss of Szl and Chordin either genetically in zebrafish
or by morpholino knockdown in Xenopus cause simi-
lar-strength ventralized phenotypes. Thus, under nor-
mal physiological conditions in the embryo, most Chor-
din function depends on Szl protection from Tolloid/
Xolloid proteolysis. In zebrafish the chordino mutant
phenotype is distinctly stronger than the ogon (sizzled)
ventralized phenotype, indicating that Chordin does
function in the absence Szl (Ogon) and thus all of its ac-
tivity does not depend on Szl (Miller-Bertoglio et al.,
1999; Yabe et al., 2003), providing that a second Szl-re-
lated gene is not also functioning in zebrafish.
So does Szl simply protect Chordin from Tolloid pro-
teases that would otherwise eliminate its activity? When
Szl is overexpressed and presumably removes all Toll-
oid proteolytic activity, zebrafish embryos become
strongly dorsalized (in a chordin-dependent manner)
with dorsal neural tissue extending circumferentially
around the dorsoventral axis (Yabe et al., 2003), indicat-
ing a loss of all BMP signaling. Thus, in the absence of
Tolloid proteolysis in the embryo, Chordin eliminates
all BMP activity. In the absence of Szl protection, Toll-
oids block most or all Chordin activity. So Tolloid is
needed to keep Chordin from antagonizing all BMP sig-
naling. And Szl keeps Tolloid from cleaving all (or most)
Chordin. Thus Szl levels must be modulated, so that
Tolloid activity is not abolished, otherwise Chordin will
eliminate all BMP signaling. How are the levels of Szl
regulated? What role does Szl play in generating differ-
ent levels of Chordin and ultimately the BMP gradient?
How instructive is its role?
Like other ventrally expressed genes, szl expression
is positively regulated by BMP signaling (Figure 1). Sur-
prisingly, the factor that Szl antagonizes, Xlr, is also ex-
pressed ventrally, whereas chordin expression is re-
stricted to dorsal regions, not overlapping with either
szl or xlr. What are the biologically relevant domains
where Szl, Chordin, and Tolloids interact? It is known
that Chordin can act at a distance. At what distance
do Xlr and Szl act from their expression domains? Is
the relative extent of these distances significant in gen-
erating differential BMP signaling?
What makes Szl distinct from other sFRPs and con-
fers its ability to bind and inhibit Tolloids, and inability
to antagonize Wnt signaling? Does Szl bind to the active
site of Tolloids or does it, for example, instead alter the
conformation of Tld, making it unable to bind its sub-
strate, while substrate binding prevents Szl binding.
Why is Chordin so highly regulated, while the other
key gastrula antagonists modulating BMP signaling,
Noggin and Follistatin (Khokha et al., 2005), appear
not to be? These and other questions remain.
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Mammalian Variations on a Theme:
A Smo and Sufu Surprise
Hedgehog signaling plays a critical role during devel-
opment and tumorigenesis. While much mechanistic
insight has come from pathway investigations in the
fruit fly, recent studies suggest a distinct mammalian
strategy for signaling from Smoothened to Gli through
the novel protein Suppressor of Fused that may have
therapeutic implications.
The challenge of developing therapeutic inhibitors and
activators of major signaling pathways comes when
the targets at which one aims keep moving. This is the
case with the components of the hedgehog (Hh) signal-
ing pathway in mammals. Hh plays a crucial role in de-
velopment and tumorigenesis in metazoan organisms
and promotes proliferation, inhibits differentiation, and
controls migration of stem cells in the body. Inappropri-
ate Hh signaling results in a panoply of developmental
defects and cancers and is implicated in the induction,
maintenance, and/or metastasis of up to 25% of human
tumors (Lum and Beachy, 2004). Intense focus has been
centered around how the Hh signal transduced by the
serpentine receptor Smoothened (Smo) is interpreted
by the Gli/Cubitus interruptus (Ci) zinc finger family of
transcription factors, as this interpretation determines
the magnitude and quality of the resultant Hh-depen-
dent target gene induction. The elegant genetic and cell
biological tools in Drosophila have provided the logic of
the pathway and identified many key components.
However, recent mammalian studies, including two in
this issue of Developmental Cell, reveal critical differ-
ences that have implications for therapeutic targeting.
In both the invertebrate and vertebrate pathways, Hh
ligand binds and inhibits the Patched receptor, allowing
Smo to tip the balance of activity of the Gli/Ci proteins
from repression to activation (Figure 1). Smo does thisKhokha, M.K., Yeh, J., Grammer, T.C., and Harland, R.M. (2005).
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in a graded fashion in two ways. First, Smo blocks pro-
tein kinase-dependent Gli3/Ci repressor formation that
occurs through the cleavage of full-length Gli3/Ci into
a smaller transcriptional repressor. Blocking this cleav-
age allows low-level expression of derepressed Hh tar-
get genes. Second, for higher levels of pathway activity,
Smo also enhances the full-length, activator forms of
Gli/Ci. In mammals the main activators are Gli1 and Gli2.
Surprising recent data indicates that mammals have
adopted distinct strategies to control Smo signal trans-
mission to Gli. In flies, the atypical kinesin protein cos-
tal2 (Cos2) is a key interpreter of the signal from Smo.
It does so by scaffolding Ci on vesicles with cleavage-
promoting kinases, thus allowing Ci phosphorylation
and subsequent Ci repressor formation (Zhang et al.,
2005). With the addition of Hh, Smo binds and seques-
ters Cos2 away from the kinases, preventing efficient
Ci repressor formation. Moreover, Cos2 appears to play
an additional role in stimulating activator forms. This is
done by scaffolding the kinase Fused, which acts posi-
tively to increase the transcriptional activity of full-
length Ci (Kalderon, 2004).
By contrast, Varjosalo and colleagues in this issue
show that in mammals Cos2 orthologs KIF7 and KIF27
are not required to regulate Sonic hedgehog (Shh) sig-
naling (Varjosalo et al., 2006). siRNAs that reduce KIF
levels in a variety of cells fail to alter Gli transcription,
suggesting that they no longer serve a function or that
other mammalian kinases can function in their place.
While this study was done in vitro and may not reflect
signaling in the animal, the authors further show that
Smo signaling is also different both in vitro and in trans-
genic animals. Mouse Smo altered in regions corre-
sponding to mutations in fly Smo that disrupt Cos2
binding fail to have identifiable effects on the pathway.
Independent pharmacologic support for a difference
comes from the observation that cyclopamine, a natural
product inhibitor of mammalian Smo, is apparently inac-
tive against fly Smo (Lum and Beachy, 2004). These
three pieces of data, in combination with recent finding
